ArticleParasites & vectors2026
Field evaluation of a novaluron-based larvicide tablet (MOSQINOk
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLarval source management remains a potentially important supplementary strategy for malaria vector control, particularly in irrigated agroecosystems, where mosquito breeding habitats are relatively stable and predictable. This study evaluated the operational effectiveness of a novaluron-based larvicide tablet (MOSQINOk
methodsA quasi-experimental controlled field study was conducted between September and December 2025 in two irrigated rice-growing communities in the Central River Region of The Gambia. Janjangbureh was assigned as the intervention site and Sankuli Kunda as the untreated control. Larval habitats were monitored weekly, while adult mosquitoes were collected biweekly using CDC light traps. Difference-in-differences analyses using negative binomial generalized estimating equation models were used to estimate intervention effects.
resultsMOSQINOk
conclusionsThese findings provide preliminary evidence that MOSQINOk
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.